In addition, the identification of such genes should reveal more about the molecular pathway causing the disease, thus suggesting new and relevant targets for more efficient drug treatment.
However, knock-out lines incur in a resolution problem: they cannot distinguish between phenotypes caused by the absence of synaptic transmission, and phenotypes arising from the disruption of molecular signaling pathways caused by the absence of crucial molecules such as ACh or AChR, which may lead to non-physiologically relevant alterations.
Diverse genetic causes and molecular pathways have been implicated, involving ion channels, and proteins needed for synaptic, regulatory, and developmental functions.
To date, only a small number of groups have focused on developing tools, or identifying molecular pathways that cause mouse or human PSC lines to undergo cultural adaptation and neoplastic progression [1], [2], [3], [4], [5], [6], [7], [8], [9].
Disruptions in these molecular pathways can cause disease.
Recent research has demonstrated that mtDNA participates in different kinds of innate immune modulation, by activating molecular pathways or causing pathologies.
With increasing knowledge of the molecular pathways that cause immunosenescence, therapeutic interventions can be designed to slow or halt the seemingly inevitable deterioration of protective immunity with aging.
Therefore, the congenital hypothyroidism model disturbs ERK 1/2 and p38MAPK phosphorylation pathways causing an important molecular alteration in the hippocampus.
Upon contact of blood with foreign material, blood cells and molecular pathways are triggered causing activation of coagulation and inflammation.
